Randomized controlled trial2024Open access

A randomized controlled cross-over trial investigating the acute inflammatory and metabolic response after meals based on red meat, fatty fish, or soy protein: the postprandial inflammation in rheumatoid arthritis (PIRA) trial

Hulander E, Bärebring L, Winkvist A, Gjertsson I, Lindqvist HM

European journal of nutrition · 9 citations

Review labels

Controlled feeding

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Randomized controlled trial (indexed by PubMed)
Studied in
People
Main outcome
Health markers and function
Intake measured by
Food provided by researchers

Who paid for it

Funding
Independent funding
Government
Vetenskapsrådet
University or hospital
Sahlgrenska Universitetssjukhuset
University or hospital
Göteborgs Universitet
University or hospital
University of Gothenburg

Based on 4 listed funder(s) and full-text disclosure statement.

Publication

Published
2024-06-27 · Eur J Nutr · vol. 63 · issue 7 · pp. 2631–2642
Publisher
Springer Science+Business Media
Cited
9 citations · more than 90% of similar papers · 2.6× the field average
References
44 works
Access
Open access (hybrid journal) · CC-BY
Research areas
Phytoestrogen effects and research · Fatty Acid Research and Health · Rheumatoid Arthritis Research and Therapies
Keywords
Postprandial, Very low-density lipoprotein, Rheumatoid arthritis, Red meat, Medicine, Crossover study, Meal, Blood lipids, Soy protein, Food science, Internal medicine, Lipoprotein, Cholesterol, Biology, Placebo, Insulin
MeSH
animals, fishes, humans, arthritis, rheumatoid, inflammation, lipids, triglycerides, soybean proteins, interleukin-6, cross-over studies, postprandial period, seafood, adult, aged, middle aged, female, male, meals, red meat

5 authors

From SE

  • Erik Hulander · correspondingUniversity of Gothenburg
  • Linnea BärebringUniversity of Gothenburg
  • Anna WinkvistUniversity of Gothenburg
  • Inger GjertssonUniversity of Gothenburg
  • Helen M. LindqvistUniversity of Gothenburg

Abstract

Purpose

Rheumatoid Arthritis (RA) has a point prevalence of around 20 million people worldwide. Patients with RA often believe that food intake affects disease activity, and that intake of red meat aggravate symptoms. The main objective of the Postprandial Inflammation in Rheumatoid Arthritis (PIRA) trial was to assess whether postprandial inflammation and serum lipid profile are affected differently by a meal including red meat, fatty fish, or a soy protein (vegan) meal.

Methods

Using a randomized controlled crossover design, 25 patients were assigned to eat isocaloric hamburger meals consisting of red meat (60% beef, 40% pork), fatty fish (salmon), or soy protein for breakfast. Blood samples were taken before meals and at intervals up to 5 h postprandial. The analysis included the inflammation marker interleukin 6 (IL-6) and serum lipids.

Results

No significant differences in postprandial IL-6 or triglyceride concentrations were found between meals. However, the area under the curve of very low density lipoprotein (VLDL) particle counts, as well as VLDL-4-bound cholesterol, triglycerides, and phospholipids, was higher after the fatty fish compared to both red meat and soy protein.

Conclusion

Postprandial inflammation assessed by IL-6 did not indicate any acute negative effects of red meat intake compared to fatty fish- or soy protein in patients with RA. The fatty fish meal resulted in a higher number of VLDL-particles and more lipids in the form of small VLDL particles compared to the other protein sources.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.